Searching for biomarkers of chronic obstructive pulmonary disease using proteomics: The current state
暂无分享,去创建一个
Marco Fumagalli | P. Iadarola | M. Fumagalli | Maddalena Cagnone | S. Viglio | A. Bardoni | Maddalena Cagnone | Roberta Salvini | Anna Bardoni | Paolo Iadarola | Simona Viglio | R. Salvini
[1] A. Amin,et al. Treatment patterns for patients hospitalized with chronic obstructive pulmonary disease , 2018, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[2] S. Ohlmeier,et al. Elevated sputum BPIFB1 levels in smokers with chronic obstructive pulmonary disease: a longitudinal study. , 2015, American journal of physiology. Lung cellular and molecular physiology.
[3] S. Ohlmeier,et al. Proteomics of human lung tissue identifies surfactant protein A as a marker of chronic obstructive pulmonary disease. , 2008, Journal of proteome research.
[4] Ming Xu,et al. Identification of thyroxine-binding globulin as a candidate plasma marker of chronic obstructive pulmonary disease , 2017, International journal of chronic obstructive pulmonary disease.
[5] J. Bandow,et al. Improved image analysis workflow for 2‐D gels enables large‐scale 2‐D gel‐based proteomics studies – COPD biomarker discovery study , 2008, Proteomics.
[6] I. Rahman,et al. Hemoglobin α and β are ubiquitous in the human lung, decline in idiopathic pulmonary fibrosis but not in COPD , 2010, Respiratory research.
[7] P. Iadarola,et al. Spit it out! How could the sputum proteome aid clinical research into pulmonary diseases? , 2017, Expert review of proteomics.
[8] T. Nishimura,et al. Recent mass spectrometry-based proteomics for biomarker discovery in lung cancer, COPD, and asthma , 2017, Expert review of proteomics.
[9] Fabio Ferrari,et al. Proteomic analysis of exhaled breath condensate from single patients with pulmonary emphysema associated to alpha1-antitrypsin deficiency. , 2008, Journal of proteomics.
[10] S D Varfolomeev,et al. [Proteomic analysis of exhaled breath condensate for diagnosis of pathologies of the respiratory system]. , 2015, Biomeditsinskaia khimiia.
[11] B. Nicholas,et al. Induced sputum: a window to lung pathology. , 2009, Biochemical Society transactions.
[12] S. Kjellqvist,et al. Gender differences in the bronchoalveolar lavage cell proteome of patients with chronic obstructive pulmonary disease. , 2013, The Journal of allergy and clinical immunology.
[13] I. Kema,et al. The role of liquid chromatography-tandem mass spectrometry in the clinical laboratory. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[14] D. Postma,et al. Proteomics of epithelial lining fluid obtained by bronchoscopic microprobe sampling. , 2011, Methods in molecular biology.
[15] C. Bai,et al. Alterations of plasma inflammatory biomarkers in the healthy and chronic obstructive pulmonary disease patients with or without acute exacerbation. , 2012, Journal of proteomics.
[16] K. R. Chapman,et al. Epidemiology and costs of chronic obstructive pulmonary disease , 2006, European Respiratory Journal.
[17] G. Paone,et al. Blood and sputum biomarkers in COPD and asthma: a review. , 2016, European review for medical and pharmacological sciences.
[18] E. Kunter,et al. Effect of Corticosteroids on Hemostasis and Pulmonary Arterial Pressure during Chronic Obstructive Pulmonary Disease Exacerbation , 2006, Respiration.
[19] L. Wood,et al. Identification of novel diagnostic biomarkers for asthma and chronic obstructive pulmonary disease. , 2011, American journal of respiratory and critical care medicine.
[20] J. Dalton,et al. Proteomic Analysis of Extracellular HMGB1 Identifies Binding Partners and Exposes Its Potential Role in Airway Epithelial Cell Homeostasis. , 2018, Journal of proteome research.
[21] Ming Xu,et al. Fetuin-B (FETUB): a Plasma Biomarker Candidate Related to the Severity of Lung Function in COPD , 2016, Scientific Reports.
[22] J. Lammers,et al. Proteomic profiling of peripheral blood neutrophils identifies two inflammatory phenotypes in stable COPD patients , 2017, Respiratory Research.
[23] P. Howarth,et al. Identification of lipocalin and apolipoprotein A1 as biomarkers of chronic obstructive pulmonary disease. , 2010, American journal of respiratory and critical care medicine.
[24] A. Lindberg,et al. Proteolytic biomarkers are related to prognosis in COPD- report from a population-based cohort , 2018, Respiratory Research.
[25] R. Banerjee,et al. Transcriptomics, proteomics and metabolomics driven biomarker discovery in COPD: an update , 2016, Expert review of molecular diagnostics.
[26] L. Teran,et al. Personalized Medicine in Respiratory Disease: Role of Proteomics. , 2016, Advances in protein chemistry and structural biology.
[27] N. Taniguchi,et al. Fucosylated surfactant protein-D is a biomarker candidate for the development of chronic obstructive pulmonary disease. , 2015, Journal of proteomics.
[28] K. Rabe,et al. Five good reasons to read (and cite) the ERJ , 2008, European Respiratory Journal.
[29] L. Pannell,et al. Protein networks in induced sputum from smokers and COPD patients , 2015, International journal of chronic obstructive pulmonary disease.
[30] M. T. Santini,et al. Structural alterations in erythrocytes from patients with chronic obstructive pulmonary disease. , 1997, Haemostasis.
[31] Eun Joo Lee,et al. Proteomic analysis in lung tissue of smokers and COPD patients. , 2009, Chest.
[32] Alan D. Lopez,et al. The global burden of disease, 1990–2020 , 1998, Nature Medicine.
[33] A. Mangoni,et al. Plasma Proteomic Signatures in Early Chronic Obstructive Pulmonary Disease , 2018, Proteomics. Clinical applications.
[34] R. Stockley. Biomarkers in chronic obstructive pulmonary disease: confusing or useful? , 2014, International journal of chronic obstructive pulmonary disease.
[35] Q. Hu,et al. Large-scale, ion-current-based proteomics investigation of bronchoalveolar lavage fluid in chronic obstructive pulmonary disease patients. , 2014, Journal of proteome research.
[36] J. Takeda,et al. New bronchoscopic microsample probe to measure the biochemical constituents in epithelial lining fluid of patients with acute respiratory distress syndrome , 2001, Critical care medicine.
[37] Michael Vogeser,et al. A decade of HPLC-MS/MS in the routine clinical laboratory--goals for further developments. , 2008, Clinical biochemistry.
[38] Xiangdong Wang,et al. Selection of AECOPD-specific immunomodulatory biomarkers by integrating genomics and proteomics with clinical informatics , 2018, Cell Biology and Toxicology.
[39] R. Savino,et al. Asthma and COPD proteomics: Current approaches and future directions , 2015, Proteomics. Clinical applications.
[40] S. Ohlmeier,et al. Sputum proteomics identifies elevated PIGR levels in smokers and mild-to-moderate COPD. , 2012, Journal of proteome research.
[41] Liangliang Sun,et al. Over 4100 protein identifications from a Xenopus laevis fertilized egg digest using reversed‐phase chromatographic prefractionation followed by capillary zone electrophoresis–electrospray ionization–tandem mass spectrometry analysis , 2016, Proteomics.
[42] D. Postma,et al. Proteomic analysis of human epithelial lining fluid by microfluidics‐based nanoLC‐MS/MS: A feasibility study , 2013, Electrophoresis.
[43] P. Montuschi,et al. Liquid chromatography-mass spectrometry measurement of leukotrienes in asthma and other respiratory diseases. , 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[44] S. Ohlmeier,et al. Biomarkers in Lung Diseases : from Pathogenesis to Prediction to New Therapies Lung tissue proteomics identifies elevated transglutaminase 2 levels in stable chronic obstructive pulmonary disease , 2016 .
[45] Jun Wang,et al. Bioinformatics-based identification of potential microRNA biomarkers in frequent and non-frequent exacerbators of COPD , 2018, International journal of chronic obstructive pulmonary disease.
[46] Å. Wheelock,et al. Long-term smoking alters abundance of over half of the proteome in bronchoalveolar lavage cell in smokers with normal spirometry, with effects on molecular pathways associated with COPD , 2018, Respiratory Research.
[47] Jason Liao,et al. Proteomic profiling of human plasma by iTRAQ reveals down-regulation of ITI-HC3 and VDBP by cigarette smoking. , 2011, Journal of proteome research.
[48] T. Franz,et al. Respiratory proteomics: from descriptive studies to personalized medicine. , 2015, Journal of proteome research.
[49] C. Tinelli,et al. Profiling the Proteome of Exhaled Breath Condensate in Healthy Smokers and COPD Patients by LC-MS/MS , 2012, International journal of molecular sciences.
[50] B. Himes,et al. Using omics approaches to understand pulmonary diseases , 2017, Respiratory Research.
[51] Kelly A. Jones,et al. Assessment of two immunodepletion methods: off-target effects and variations in immunodepletion efficiency may confound plasma proteomics. , 2012, Journal of proteome research.
[52] Giovanna E Carpagnano,et al. Peptidome profiling of induced sputum by mesoporous silica beads and MALDI‐TOF MS for non‐invasive biomarker discovery of chronic inflammatory lung diseases , 2011, Proteomics.
[53] L. Pannell,et al. Protein expression in sputum of smokers and chronic obstructive pulmonary disease patients: a pilot study by CapLC-ESI-Q-TOF. , 2007, Journal of proteome research.
[54] Marinos Elia,et al. Influence of deprivation on health care use, health care costs, and mortality in COPD , 2018, International journal of chronic obstructive pulmonary disease.
[55] Richard D. Smith,et al. Proteomic biomarkers in plasma that differentiate rapid and slow decline in lung function in adult cigarette smokers with chronic obstructive pulmonary disease (COPD) , 2010, Analytical and bioanalytical chemistry.
[56] H. Salehi,et al. Chronic obstructive pulmonary disease: MicroRNAs and exosomes as new diagnostic and therapeutic biomarkers , 2018, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.
[57] T. Veenstra,et al. Profiling the erythrocyte membrane proteome isolated from patients diagnosed with chronic obstructive pulmonary disease. , 2012, Journal of proteomics.
[58] F. Hargreave,et al. The use of cellular and molecular biomarkers to manage COPD exacerbations , 2017, Expert review of respiratory medicine.
[59] D. Halpin,et al. Chronic obstructive pulmonary disease guidelines in Europe: a look into the future , 2018, Respiratory Research.
[60] M. Strlič,et al. Depletion of high-abundance proteins from human plasma using a combination of an affinity and pseudo-affinity column. , 2009, Journal of chromatography. A.
[61] B. McManus,et al. COPD Exacerbation Biomarkers Validated Using Multiple Reaction Monitoring Mass Spectrometry , 2016, PloS one.
[62] B. Garcia,et al. Proteomics , 2011, Journal of biomedicine & biotechnology.
[63] M. Neurath,et al. RAGE Mediates a Novel Proinflammatory Axis A Central Cell Surface Receptor for S100/Calgranulin Polypeptides , 1999, Cell.
[64] L. Paz-Ares,et al. Identification of proteomic signatures associated with lung cancer and COPD. , 2013, Journal of proteomics.
[65] S. Ohlmeier,et al. Proteomic studies on receptor for advanced glycation end product variants in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease , 2010, Proteomics. Clinical applications.
[66] R. M. Ford. Allergy in asthma , 1982 .
[67] Fabio Ferrari,et al. From micellar electrokinetic chromatography to liquid chromatography‐mass spectrometry: Revisiting the way of analyzing human fluids for the search of desmosines, putative biomarkers of chronic obstructive pulmonary disease , 2014, Electrophoresis.
[68] A. Fernández-Villar,et al. Reliability and usefulness of spirometry performed during admission for COPD exacerbation , 2018, PloS one.
[69] D. Porteous,et al. SELDI-TOF biomarker signatures for cystic fibrosis, asthma and chronic obstructive pulmonary disease. , 2010, Clinical biochemistry.
[70] Per Broberg,et al. Protein expression patterns associated with progression of chronic obstructive pulmonary disease in bronchoalveolar lavage of smokers. , 2007, Clinical chemistry.
[71] C. Brightling. Chronic obstructive pulmonary disease phenotypes, biomarkers, and prognostic indicators. , 2016, Allergy and asthma proceedings.
[72] J. Enghild,et al. Human skin keratins are the major proteins in exhaled breath condensate , 2008, European Respiratory Journal.
[73] Charles Auffray,et al. Application of ’omics technologies to biomarker discovery in inflammatory lung diseases , 2013, European Respiratory Journal.
[74] Å. Wheelock,et al. Proteomic profiling of lung immune cells reveals dysregulation of phagocytotic pathways in female-dominated molecular COPD phenotype , 2018, Respiratory Research.
[75] M. Peitsch,et al. Alterations in the sputum proteome and transcriptome in smokers and early-stage COPD subjects. , 2015, Journal of proteomics.
[76] R. Bowler,et al. Analysis of the Plasma Proteome in COPD: Novel Low Abundance Proteins Reflect the Severity of Lung Remodeling , 2014, COPD.
[77] R. Savino,et al. Application of Proteomics and Peptidomics to COPD , 2014, BioMed research international.
[78] L. Paz-Ares,et al. Identification of Oxidative Stress Related Proteins as Biomarkers for Lung Cancer and Chronic Obstructive Pulmonary Disease in Bronchoalveolar Lavage , 2013, International journal of molecular sciences.
[79] P. Barnes,et al. Chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.
[80] T. Welte,et al. Does urinary peptide content differ between COPD patients with and without inherited alpha-1 antitrypsin deficiency? , 2017, International journal of chronic obstructive pulmonary disease.
[81] D. Porteous,et al. Sputum proteomics in inflammatory and suppurative respiratory diseases. , 2008, American journal of respiratory and critical care medicine.
[82] D. Postma,et al. Susceptibility to COPD: Differential Proteomic Profiling after Acute Smoking , 2014, PloS one.